ZARONTIN 250 MG CAPSULE

Ethosuximide
$1.3086per EA
High Outlier

Strength

250 mg/1

Manufacturer

Pfizer Inc.

NDC

00071023724

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

ETHOSUXIMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA012380

On Market Since

9/22/2000

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.7%

1Y

-63.1%

3Y

-63.1%

5Y

-63.1%

All

-30.9%